Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
63 Leser
Artikel bewerten:
(0)

Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw to Executive Officer

LINCOLNSHIRE, Ill., July 23, 2014 /PRNewswire/ --Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of Sysmex Corporation. Kershaw's appointment marks the first time an executive from an overseas subsidiary has been appointed. As an Executive Officer, Kershaw will serve in a consultative capacity to the corporation's president and governing board while maintaining his leadership position with Sysmex America.

Sysmex America, Inc. Logo.

Sysmex America has oversight of the company's subsidiaries in Canada, Latin America and the Caribbean. Sysmex is a global leader in medical diagnostic testing equipment and information systems technology and services hospitals and healthcare networks, reference laboratories and physicians offices worldwide.

During Kershaw's leadership, the U.S. subsidiary has achieved major milestones including significant North American market share growth and international expansion to the Latin American and Caribbean markets. Additionally, the company has introduced industry-changing products in those markets such as the Sysmex® XN-Series Automated Hematology Analyzers and Sysmex WAM' Middleware. The company has also been recognized by national entities for its outstanding workplace practices and active community involvement and has opened a Research & Development Center to help accelerate the globalization of the Corporation's R & D structure with the goal of realizing personalized medicine.

Kershaw's 23-year career with Sysmex Corporation, Kobe, Japan, began as a result of the company's acquisition of L.E.P. Scientific in 1991. His experience as the Manager of Sales and Marketing in the newly formed subsidiary eventually led him to serve as the Marketing Director for Sysmex's corporate European headquarters in Hamburg, Germany.

Three years after relocating to Hamburg, Kershaw was promoted to Vice President of Sysmex Europe where he directed the efforts of all of Sysmex's European business operations. A market growth rate of 18% in a two-year period under his leadership resulted in Kershaw's promotion yet again to Executive Vice President and Board Member for Sysmex Europe. At that time, he was also appointed to serve as a board member of Sysmex's software company located in Belgium, Sysmex MOLIS.

As a result of Sysmex's strategic move to establish a new software products business in the United States and the requirement to lead an aggressive growth campaign in the Laboratory Diagnostics division of the company, Kershaw was transferred to America where he became Chief Operating Officer, Managing Director, and a Board Member of Sysmex's U.S. headquarters, Sysmex Corporation of America, now known as Sysmex America, Inc.

Kershaw's education lies in the areas of hematology, microbiology, biochemistry, immunology, anatomic pathology and blood transfusion. He is a fellow of the Association of Medical Technologists in the United Kingdom and serves as a board member of AdvaMed.

About Sysmex America, Inc.

Sysmex America, Inc., in Lincolnshire, Illinois, the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a trusted world leader in clinical laboratory systemization and solutions that optimize the clinical utility, operational efficiency and financial performance of the lab. Sysmex America distributes and supports a diversified portfolio of best-in-class automated in vitro diagnostic hematology, coagulation and urinalysis analyzers, reagents and information systems for laboratories and healthcare facilities throughout the Western Hemisphere. The Company's unwavering commitment to clinical excellence and technological innovation is reflected in the Sysmex brand and its distinguished heritage of unsurpassed reliability. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex, please visit www.sysmex.com/us

Logo - http://photos.prnewswire.com/prnh/20130612/CG30721LOGO-b

SOURCE Sysmex America, Inc.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.